TCA
BSX icon

Taconic Capital Advisors’s Boston Scientific BSX Stock Holding History

Taconic Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-370,000
Closed -$16.4M – 703
2022
Q1 		$16.4M Buy
+370,000
New +$16M 0.44% 35
2021
Q1 		– Sell
-150,000
Closed -$5.39M – 378
2020
Q4 		$5.39M Buy
+150,000
New +$5.41M 0.24% 79
2020
Q2 		– Sell
-125,000
Closed -$4.08M – 54
2020
Q1 		$4.08M Buy
+125,000
New +$4.88M 0.24% 40
2018
Q4 		– Sell
-50,000
Closed -$1.81M – 53
2018
Q3 		$1.93M Buy
+50,000
New +$1.75M 0.19% 35

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Taconic Capital Advisors's BSX Position: Q2 2022 in Review

Taconic Capital Advisors sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 370,000 shares — an estimated $16.4M sold.

Taconic Capital Advisors first reported a position in BSX in Q3 2018 and held it in 4 quarters. The position peaked at $16.4M in Q1 2022. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Taconic Capital Advisors reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Taconic Capital Advisors sold 370,000 Boston Scientific shares in Q2 2022, an estimated $16.4M.
  • Taconic Capital Advisors first reported a position in Boston Scientific in Q3 2018 and held it in 4 quarters.
  • Taconic Capital Advisors's Boston Scientific position peaked at $16.4M in Q1 2022.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Taconic Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.